Dr. Green is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
907 E Lamar Alexander Pkwy
Maryville, TN 37804Phone+1 865-977-5534
Education & Training
Duke University HospitalResidency, Radiation Oncology, 1986 - 1989
Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalFellowship, Hematology and Medical Oncology, 1984 - 1986- Dartmouth-Hitchcock/Mary Hitchcock Memorial HospitalResidency, Internal Medicine, 1981 - 1984
Vanderbilt University School of MedicineClass of 1981
Certifications & Licensure
TN State Medical License 1989 - 2025
NC State Medical License 1987 - 2003
VT State Medical License 1983 - 1986- American Board of Internal Medicine Internal Medicine
- American Board of Radiology Radiation Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification ARIA Radiation Oncology EMR, Varian Medical Systems, 2013-2014
Clinical Trials
- Chemotherapy With or Without Surgery, Radiation Therapy, or Stem Cell Transplantation in Treating Young Patients With Kidney Tumors Start of enrollment: 1996 Jan 01
- Combination Chemotherapy Alone or With Radiation Therapy in Treating Children With Kidney Cancer Start of enrollment: 1995 Jul 01
Publications & Presentations
PubMed
- 296 citationsThe Cyclophosphamide Equivalent Dose as an Approach for Quantifying Alkylating Agent Exposure. A Report from the Childhood Cancer Survivor StudyDaniel M. Green, Vikki G. Nolan, Pamela Goodman, John Whitton, Deo Kumar Srivastava
Pediatric Blood & Cancer. 2014-01-01 - 171 citationsIndividual Prediction of Heart Failure Among Childhood Cancer SurvivorsEric J. Chow, Yan Chen, Leontien C. M. Kremer, Norman E. Breslow, Melissa M. Hudson
Journal of Clinical Oncology. 2015-02-10 - 851 citationsClinical Ascertainment of Health Outcomes Among Adults Treated for Childhood CancerMelissa M. Hudson, Kirsten K. Ness, James G. Gurney, Daniel A. Mulrooney, Wassim Chemaitilly
JAMA. 2013-06-12
Journal Articles
- Serum ALT Elevations in Survivors of Childhood Cancer. A Report from the St. Jude Lifetime Cohort StudyMatthew J Krasin, Sima Jeha, Daniel M Green, Melissa M Hudson, Wayne L Furman, Michael W Bishop, Hepatology
Grant Support
- Long-Term Complications Of Children/Adolescents &CancerNational Cancer Institute2008–2011
- Long-Term Complications Of Children/Adolescents &CancerNational Cancer Institute2002–2006
- Nwtsg Foreign AccrualNational Cancer Institute2003
- National Wilms Tumor Study -5National Cancer Institute2000–2003
- Biological Prognostic Factors In Wilms TumorNational Cancer Institute1999
- National Wilms Tumor Study--5National Cancer Institute1995–1999
- Conference On The Complications Of TreatmentNational Cancer Institute1998
- Biological Prognostic Factors In Wilms TumorNational Cancer Institute1998
- National Wilms Tumor StudyNational Cancer Institute1994–1998
- Conference Of The Complications Of TreatmentNational Cancer Institute1996
- Biologic Prognostic Variables In Wilms Tumor PatientsNational Cancer Institute1993–1995
- National Wilms'Tumor Study-4National Cancer Institute1991–1993
- Conference On The Complications Of TreatmentNational Cancer Institute1992
- Complications Of TreatmentNational Cancer Institute1990
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
